Pharmaceutical Technology

JANUARY 14, 2025

This month, pharma companies have announced plans to increase the prices of more than 250 branded drugs in the US.

Pharma 76

Pharma Marketing 76

MedCity News

JANUARY 14, 2025

More than a decade ago, Medtronic announced that a pivotal trial testing its renal denervation system had failed. Though it got approved later, reimbursement has been elusive. All that might change this year. The post Is Medtronic On the Cusp of Rewriting the Story of Renal Denervation? appeared first on MedCity News.

75

75

Healthcare Success

JANUARY 14, 2025

How can healthcare companies use marketing and branding to drive growth and reduce risks in preparation for mergers and acquisitions (M&A)? In this podcast, Victora Shepherd and I explore the critical role of brand integration throughout the M&A lifecycle, with a focus on private equity-backed healthcare companies. We discuss why marketing and brand strategy are often overlooked despite their ability to boost shareholder value by over 23% and improve M&A success rates by 42% [ Source

Marketing 52

Marketing Healthcare Healthcare Media 52

MedCity News

JANUARY 14, 2025

In an interview, Zelis CEO Amanda Eisel shared her perspective on how the company is solving the problems of a fragmented health financial system to benefit all. The post Improving the Healthcare Financial Experience to Help Care Flow appeared first on MedCity News.

Healthcare 73

Healthcare Healthcare Physicians 73

Advertiser: ZoomInfo

Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.

Sales

PharmaTimes

JANUARY 14, 2025

First-in-human trial of PTD802 to commence following UK MHRA approval

64

64

MedCity News

JANUARY 14, 2025

Revenue for the blockbuster Eli Lilly drugs Mounjaro and Zepbound continues to grow, but not as much as expected. At the J.P. Morgan Healthcare Conference, Lilly CEO David Ricks explained why the company revised downward its projections for fourth quarter 2024 revenue. The post At JPM, Eli Lillys CEO Explains Why Mounjaro, Zepbound Sales Were Lower Than Expected appeared first on MedCity News.

Sales 62

Sales Healthcare Healthcare Biopharma 62

MedCity News

JANUARY 14, 2025

A new eBook by Elation Health offers a checklist to help primary care practices maintain and grow in the face of these myriad challenges. The post A Strategic Growth Plan for Primary Care Practices appeared first on MedCity News.

59

59

Pharmaceutical Technology

JANUARY 14, 2025

Eight blockbuster drugs are expected to generate over $3bn in peak sales each according to Novartis CEO Vas Narasimhan.

Sales 59

Sales 59

Pharmaceutical Commerce

JANUARY 14, 2025

The latest news for pharma industry insiders.

Pharma 59

Pharma 59

Pharmaceutical Technology

JANUARY 14, 2025

The acquisition builds on a 2017 option agreement and subsequent 2018 licensing deal with Glycotope.

59

59

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Pharmaceutical Commerce

JANUARY 14, 2025

In the third part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Mark Jara, founder and CTO, RxS, shares his inspiration behind designing SampleHub.

Pharma 59

Pharma 59

Pharmaceutical Technology

JANUARY 14, 2025

Intra-Cellulars clinical-stage pipeline is promising, with pipeline agents under development for a wide range of neurological indications.

59

59

PharmaVoice

JANUARY 14, 2025

Merck looks ahead with an array of cardiometabolic, immunology, neuroscience and ophthalmology pipelines.

59

59

Pharmaceutical Technology

JANUARY 14, 2025

CEO Stphane Bancel emphasised saving cash as integral in the companys bid to parlay Covid-19 profits into future profitability.

59

59

Advertiser: ZoomInfo

In today’s ultra-competitive markets, it’s no longer enough to wait for buyers to show obvious signs of interest. Instead, sales teams must be proactive, identifying and acting on nuanced buyer behaviors — often before prospects are fully ready to make a purchase. In this eBook from ZoomInfo & Sell Better, learn 10 actionable ways to use these buyer signals to transform your sales strategy and close deals faster.

Sales Strategy

PharmaTimes

JANUARY 14, 2025

Initiative aims to identify plasma-based biomarkers for early detection

58

58

Pharmaceutical Technology

JANUARY 14, 2025

US-based biotech Normunity plans to initiate a Phase I clinical trial of NRM-823 in the second half of 2025.

59

59

MedCity News

JANUARY 14, 2025

Technology often plays a critical role in strategies to combat rising costs while maintaining quality care. Here are four trends expected to accelerate in 2025. The post 2025 Trends in Health IT appeared first on MedCity News.

57

57

Pharmaceutical Technology

JANUARY 14, 2025

The PDUFA action date for the more convenient autoinjector is set for August 2025.

FDA 59

FDA 59

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

pharmaphorum

JANUARY 14, 2025

Grifols has been awarded a $21m grant from the Michael J Fox Foundation to find plasma biomarkers to predict Parkinson's years before symptoms start

54

54

Pharmaceutical Technology

JANUARY 14, 2025

In a new webinar, industry experts explore how innovative technology and direct patient communication are transforming medication adherence in the UK.

Patients 59

Patients Medical 59

European Pharmaceutical Review

JANUARY 14, 2025

New long-term data reveals that a modifier gene therapy delivered meaningful visual function improvements for retinitis pigmentosa participants in a Phase I/II clinical trial. A two-year safety and efficacy update from the OCU400 clinical trial showed that 100 percent of treated evaluable participants improved or preserved their visual function compared to untreated eyes at both one and two years.

Safety 52

Safety Medicine Patients Medical 52

Pharmaceutical Technology

JANUARY 14, 2025

IFF Pharma Solutions is a winner in the Marketing category in the 2024 Pharmaceutical Technology Excellence Awards.

Pharmaceutical 59

Pharmaceutical Pharma Marketing 59

Advertiser: ZoomInfo

As prospects define their problem, search for solutions, and even change jobs, they are generating high-value signals that the best go-to-market teams can leverage to close more deals. This is where signal-based selling comes into play. ZoomInfo CEO Henry Schuck recently broke down specific ways to put four key buying signals into action with the experts from 30 Minutes to President’s Club.

Prospecting

pharmaphorum

JANUARY 14, 2025

NICE has said that four artificial intelligence technologies can be deployed by the NHS to detect fractures on X-rays in urgent care.

53

53

PharmaVoice

JANUARY 14, 2025

Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the controversial drug middlemen as the agency’s first report released last summer — but relies on more data.

Management 52

Management 52

pharmaphorum

JANUARY 14, 2025

FDA has started its review of an autoinjector version of Eisai and Biogen's Alzheimer's drug Leqembi that could allow patients to be dosed at home

FDA 53

FDA Patients 53

Pharmaceutical Technology

JANUARY 14, 2025

In 2023, medical dermatology represented 52% of Almirall's income with a turnover of EUR465.2m ($477.36m).

Medical 52

Medical Marketing 52

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

PharmExec

JANUARY 14, 2025

Moderna provided updates on key elements of its pipeline, including a next-generation COVID-19 vaccine, an RSV vaccine, a new seasonal flu, and a combination seasonal flu/COVID vaccine.

52

52

Pharmaceutical Technology

JANUARY 14, 2025

The CDMO's growth strategy, capital deployment approach, and work with AI, among other things, have been key to its 2024 performance.

52

52

PharmExec

JANUARY 14, 2025

Acceptance of the Biologics License Application for subcutaneous Leqembi is based on results from the Clarity AD open-label extension and modeling of observed data in patients with Alzheimer disease.

FDA 52

FDA Patients 52

Copyright Clearance Center

JANUARY 14, 2025

Copyright Clearance Center announced the election of Catie Sheret, general counsel for Cambridge University Press & Assessment to its board of directors.

52

52

Advertiser: ZoomInfo

Sales and marketing leaders have reached a tipping point when it comes to using intent data — and they’re not looking back. More than half of all B2B marketers are already using intent data to increase sales, and Gartner predicts this figure will grow to 70 percent. The reason is clear: intent can provide you with massive amounts of data that reveal sales opportunities earlier than ever before.

Sales